NNNN
NNNN
NASDAQ · Biotechnology

Anbio Biotechnology Ltd

$23.76
+0.57 (+2.46%)
Financial Highlights (FY 2026)
Revenue
27.65M
Net Income
8.02M
Gross Margin
71.9%
Profit Margin
29.0%
Rev Growth
+22.7%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 71.9% 71.9% 30.8% 30.8%
Operating Margin 24.4% 21.9% -15.2% -16.7%
Profit Margin 29.0% 27.5% -19.2% -20.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 27.65M 22.53M 1.84B 1.79B
Gross Profit 19.88M 16.20M 567.81M 552.88M
Operating Income 6.74M 4.94M -280,071,476 -300,415,133
Net Income 8.02M 5.88M -354,337,532 -367,227,211
Gross Margin 71.9% 71.9% 30.8% 30.8%
Operating Margin 24.4% 21.9% -15.2% -16.7%
Profit Margin 29.0% 27.5% -19.2% -20.5%
Rev Growth +22.7% +22.7% +17.6% +11.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 886.33M 752.45M
Total Equity 1.73B 1.94B
D/E Ratio 0.51 0.39
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 6.80M 5.26M -454,323,212 -381,836,603
Free Cash Flow -249,462,362 -276,575,086